GSK plc (LON:GSK)
London · Delayed Price · Currency is GBP · Price in GBX 2,125.00
+29.00 (1.38%)
Apr 8, 2026, 5:09 PM GMT
GSK plc Market Cap
GSK plc has a market cap or net worth of 83.77 billion as of April 8, 2026. Its market cap has increased by 38.66% in one year.
Market Cap
83.77B
Enterprise Value
97.72B
Revenue
32.67B
Ranking
n/a
PE Ratio
15.10
Stock Price
2,125.00
Market Cap Chart
Since December 27, 2000, GSK plc's market cap has increased from 64.68B to 83.77B, an increase of 29.52%. That is a compound annual growth rate of 1.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 7, 2026 | 83.77B | 14.44% |
| Dec 31, 2025 | 73.20B | 33.23% |
| Dec 31, 2024 | 54.94B | -7.05% |
| Dec 29, 2023 | 59.11B | 1.25% |
| Dec 30, 2022 | 58.38B | -27.44% |
| Dec 31, 2021 | 80.46B | 20.44% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 237.55B |
| Haleon | 33.26B |
| Smith & Nephew | 10.31B |
| Convatec Group | 4.30B |
| Hikma Pharmaceuticals | 2.83B |
| HUTCHMED (China) | 1.88B |
| Genus | 1.70B |
| Oxford Nanopore Technologies | 1.16B |